LEX Diagnostics Appoints Scott O’Brien as LEX Board Member
CAMBRIDGESHIRE, United Kingdom, Feb. 21, 2023 – LEX Diagnostics announces the appointment of Scott O’Brien as its new Board member. The company is revolutionising molecular point-of-care diagnostics with a step change in speed, sensitivity, and cost. LEX is developing a 5-minute multiplex PCR test to quickly determine the presence of infectious diseases including SARS-CoV-2 (Covid-19), Influenza, Strep A, and RSV.
